FI61897C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1-(acyloximetyl)-4-(omega-nitroguanidino)-butyl)-dihydrolysergamider samt syraadditionssalter daerav - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1-(acyloximetyl)-4-(omega-nitroguanidino)-butyl)-dihydrolysergamider samt syraadditionssalter daerav Download PDF

Info

Publication number
FI61897C
FI61897C FI751537A FI751537A FI61897C FI 61897 C FI61897 C FI 61897C FI 751537 A FI751537 A FI 751537A FI 751537 A FI751537 A FI 751537A FI 61897 C FI61897 C FI 61897C
Authority
FI
Finland
Prior art keywords
butyl
therapeutic
nitroguanidino
acid
dihydrolysergamider
Prior art date
Application number
FI751537A
Other languages
English (en)
Finnish (fi)
Other versions
FI61897B (fi
FI751537A (sk
Inventor
Erzsebet Mago
Jozsef Borsi
Endre Csanyi
Katalin Pik
Lajos Wolf
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of FI751537A publication Critical patent/FI751537A/fi
Application granted granted Critical
Publication of FI61897B publication Critical patent/FI61897B/fi
Publication of FI61897C publication Critical patent/FI61897C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI751537A 1974-05-28 1975-05-27 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1-(acyloximetyl)-4-(omega-nitroguanidino)-butyl)-dihydrolysergamider samt syraadditionssalter daerav FI61897C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO1272A HU169073B (sk) 1974-05-28 1974-05-28
HUGO001272 1974-05-28

Publications (3)

Publication Number Publication Date
FI751537A FI751537A (sk) 1975-11-29
FI61897B FI61897B (fi) 1982-06-30
FI61897C true FI61897C (fi) 1982-10-11

Family

ID=10996767

Family Applications (1)

Application Number Title Priority Date Filing Date
FI751537A FI61897C (fi) 1974-05-28 1975-05-27 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1-(acyloximetyl)-4-(omega-nitroguanidino)-butyl)-dihydrolysergamider samt syraadditionssalter daerav

Country Status (21)

Country Link
US (1) US4005089A (sk)
JP (1) JPS5218718B2 (sk)
AT (1) AT346501B (sk)
BE (1) BE829518A (sk)
BG (1) BG27374A3 (sk)
CA (1) CA1051878A (sk)
CS (1) CS194227B2 (sk)
DD (1) DD121639A5 (sk)
DE (1) DE2523743A1 (sk)
DK (1) DK143801C (sk)
ES (1) ES437994A1 (sk)
FI (1) FI61897C (sk)
FR (1) FR2272671B1 (sk)
GB (1) GB1474337A (sk)
HU (1) HU169073B (sk)
IL (1) IL47361A (sk)
NL (1) NL7506276A (sk)
PL (1) PL98944B1 (sk)
SE (1) SE419548B (sk)
SU (1) SU625612A3 (sk)
YU (1) YU135575A (sk)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064249A (en) * 1974-05-28 1977-12-20 Richter Gedeon Vegyeszeti Gyar Rt. Compounds with ergoline skeleton
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
HU172479B (hu) * 1976-03-09 1978-09-28 Gyogyszerkutato Intezet Sposob poluchenija novykh soedinenij s ehrgolenovymi i
JPS577172Y2 (sk) * 1977-03-17 1982-02-10
JPS582957U (ja) * 1981-06-30 1983-01-10 松下電子工業株式会社 高圧ナトリウムランプ
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
DD238051A1 (de) * 1985-06-10 1986-08-06 Dresden Arzneimittel Verfahren zur herstellung neuer lysergsaeureamide
US8710092B2 (en) * 2009-12-23 2014-04-29 Map Pharmaceuticals, Inc. Substituted indolo 4,3 FG quinolines useful for treating migraine
BR112013033339A2 (pt) 2011-06-23 2016-08-16 Map Pharmaceuticals Inc análogos de fluorergolina
WO2013095707A1 (en) 2011-12-19 2013-06-27 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
CA2859175A1 (en) 2011-12-21 2013-06-27 Map Pharmaceuticals, Inc. Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
CN107428745A (zh) * 2015-01-20 2017-12-01 Xoc制药股份有限公司 麦角灵化合物及其用途
BR112019025420A2 (pt) 2017-06-01 2020-06-16 Xoc Pharmaceuticals, Inc. Compostos policíclicos e usos destes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533699A (en) * 1950-12-12 Amines containing the king system
US2673850A (en) * 1951-07-28 1954-03-30 Sandoz Ag Piperazides of the lysergic acid series
US2946796A (en) * 1958-10-15 1960-07-26 Grace W R & Co Salts of ergot alkaloids
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
SE396753B (sv) * 1970-05-18 1977-10-03 Richter Gedeon Vegyeszet Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
US3901893A (en) * 1970-05-18 1975-08-26 Richter Gedeon Vegyeszet New dihydro-lysergic acid derivative
IL41409A (en) * 1972-02-04 1977-04-29 Richter Gedeon Vegyeszet Lysergic acid amides and process for their preparation

Also Published As

Publication number Publication date
AT346501B (de) 1978-11-10
DK235175A (da) 1975-11-29
GB1474337A (en) 1977-05-25
BG27374A3 (en) 1979-10-12
SE419548B (sv) 1981-08-10
IL47361A (en) 1979-11-30
DD121639A5 (sk) 1976-08-12
YU135575A (en) 1982-06-30
FI61897B (fi) 1982-06-30
ES437994A1 (es) 1977-01-16
PL98944B1 (pl) 1978-05-31
JPS5218718B2 (sk) 1977-05-24
IL47361A0 (en) 1975-07-28
ATA386375A (de) 1978-03-15
DK143801C (da) 1982-03-22
CA1051878A (en) 1979-04-03
HU169073B (sk) 1976-09-28
JPS516998A (sk) 1976-01-20
FR2272671B1 (sk) 1978-10-06
AU8142575A (en) 1976-11-25
SU625612A3 (ru) 1978-09-25
FR2272671A1 (sk) 1975-12-26
US4005089A (en) 1977-01-25
SE7505974L (sv) 1975-12-01
CS194227B2 (en) 1979-11-30
NL7506276A (nl) 1975-12-02
DK143801B (da) 1981-10-12
FI751537A (sk) 1975-11-29
DE2523743A1 (de) 1975-12-18
BE829518A (fr) 1975-09-15

Similar Documents

Publication Publication Date Title
FI61897C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1-(acyloximetyl)-4-(omega-nitroguanidino)-butyl)-dihydrolysergamider samt syraadditionssalter daerav
JP5596680B2 (ja) 経口抗がん製剤
KR100312445B1 (ko) 트리플루오로메틸피롤로인돌카르복실산 에스테르 유도체의 제조방법
FR2557110A1 (fr) Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
JP7019000B2 (ja) ２環性複素環化合物
KR20080091829A (ko) 유방암, 대장암, 췌장암, 난소암 및 폐암 치료용 7―에틸―10―히드록시캄포테신의 다분지형 고분자 접합체
KR20030072607A (ko) 트리시클릭 락탐 및 술탐 유도체, 및 히스톤 디아세틸라제억제제로서 이들의 용도
JP2009504625A (ja) ジヒドロキシアントラキノンおよびそれらの使用
US6346521B1 (en) Optically active 2R, 4S benzothiepin isomer
AU1641592A (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
EP3998262A1 (en) Nrf2-activating compound
EP0328111B1 (en) Cancer cell metastasis inhibitors
FR2775288A1 (fr) Derives de streptogramines, leur preparation et les compositons qui les contiennent
EP0072755B1 (fr) Nouveaux derivés de la cephalosporine, leur préparation et les médicaments qui les contiennent
FR2599036A1 (fr) Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
US6066667A (en) Substituted furanones, compositions and antiarthritic use
JP4310191B2 (ja) タキサン誘導体結晶およびその製造方法
CS199609B2 (en) Method of producing 6-methyl-8-isocyanmethyl ergoline
JP7503063B2 (ja) 神経変性疾患の治療のための２－フッ素化胆汁酸
US4064249A (en) Compounds with ergoline skeleton
CA2380305C (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
CH641190A5 (fr) Derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent.
JPH09508917A (ja) フェニルピロール誘導体およびそのドーパミンｄ▲下３▼アンタゴニストとしての使用
AP639A (en) Polymorphs of the pro drug 6-n-(L-Ala-L-Ala)-trovafloxacin.
EP4273145A1 (en) Nrf2-activating compound

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: RICHTER GEDEON VEGYéSZETI GYAR R.T.